Michael Nuoqing Yi
Directeur en chef des Investissements chez Hillhouse Investment Management Ltd. (Invest)
Postes actifs de Michael Nuoqing Yi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Hillhouse Investment Management Ltd. (Invest)
 Hillhouse Investment Management Ltd. (Invest) Investment ManagersFinance Hillhouse Capital Management Ltd. (Hillhouse Capital) is a Private Equity/Venture Capital firm, a subsidiary of Hillhouse Capital Group Ltd. founded in 2005 by Lei Zhang. The firm is headquartered in Hong Kong. | Directeur en chef des Investissements | - | - |
| Private Equity Investor | - | - | |
Sironax Ltd.
 Sironax Ltd. Pharmaceuticals: MajorHealth Technology Sironax Ltd. is a clinical-stage biotechnology company located in Beijing, China. The Chinese company is dedicated to discovering and developing novel treatments for patients with age-related degenerative diseases. Sironax has built a diverse pipeline of multiple programs, focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. Currently, Sironax is conducting early clinical studies with sir0365 and sir2446, in addition to ongoing preclinical research. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Michael Nuoqing Yi
Statistiques
Internationale
| Hong Kong | 2 |
| Chine | 2 |
Opérationnelle
| Chief Investment Officer | 1 |
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
Sectorielle
| Finance | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Hillhouse Investment Management Ltd. (Invest)
Hillhouse Investment Management Ltd. (Invest) Investment ManagersFinance Hillhouse Capital Management Ltd. (Hillhouse Capital) is a Private Equity/Venture Capital firm, a subsidiary of Hillhouse Capital Group Ltd. founded in 2005 by Lei Zhang. The firm is headquartered in Hong Kong. | Finance |
Sironax Ltd.
Sironax Ltd. Pharmaceuticals: MajorHealth Technology Sironax Ltd. is a clinical-stage biotechnology company located in Beijing, China. The Chinese company is dedicated to discovering and developing novel treatments for patients with age-related degenerative diseases. Sironax has built a diverse pipeline of multiple programs, focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. Currently, Sironax is conducting early clinical studies with sir0365 and sir2446, in addition to ongoing preclinical research. | Health Technology |
- Bourse
- Insiders
- Michael Nuoqing Yi
- Expérience
